• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Research on the effects of tamoxifen in rats with estrogen- and progesterone-receptor negative ovarian cancer.

Research Project

Project/Area Number 14571595
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Obstetrics and gynecology
Research InstitutionIwate Medical University

Principal Investigator

SUGIYAMA Toru  Iwate Medical University, School of Medicine, Professor, 医学部, 教授 (40162903)

Co-Investigator(Kenkyū-buntansha) IZUTSU Toshihiko  Iwate Medical University, School of Medicine, Professor, 医学部, 教授 (00103739)
YOSHIZAKI Akira  Iwate Medical University, School of Medicine, Lecturer, 医学部, 助手 (40200969)
SHOJI Tadahiro  Iwate Medical University, School of Medicine, Research Associate, 医学部, 助手 (00337148)
OTA Shunichiro  Kurume University, School of Medicine, Research Associate, 医学部, 助手 (40289476)
Project Period (FY) 2002 – 2005
Project Status Completed (Fiscal Year 2005)
Budget Amount *help
¥3,200,000 (Direct Cost: ¥3,200,000)
Fiscal Year 2005: ¥400,000 (Direct Cost: ¥400,000)
Fiscal Year 2004: ¥600,000 (Direct Cost: ¥600,000)
Fiscal Year 2003: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 2002: ¥1,300,000 (Direct Cost: ¥1,300,000)
KeywordsTamoxifen / apoptosis / cell cycle / ovarian cancer / anti-tumor effect / Ovarian Cancer / tamoxifen / rat / Estrogen receptor / estrogen receptor / Rat / Cell cycle
Research Abstract

The effects of tamoxifen (TAM) on the growth and cell cycle kinetics in an estrogen- and progesterone-receptor negative ovarian cancer in rats were evaluated. Although no macroscopic reducting effect of TAM on tumors was found, proliferation and replacement of connective tissue and the expansion of central necrosis was observed histologically. The administration of TAM (2.0mg/kg) caused a tendency to decrease S-phase cells and increase G0/G1-phase cells. These findings indicate that TAM might inhibit DNA syntheses. TAM significantly increased apoptosis cell in the Sub-G1 region on DNA cytograms in a dose-dependent manner. TAM is therefore thought to have a potentially inhibitory effect on the growth of ovarian cancer.

Report

(5 results)
  • 2005 Annual Research Report   Final Research Report Summary
  • 2004 Annual Research Report
  • 2003 Annual Research Report
  • 2002 Annual Research Report

Research Products

(62 results)

All 2005 2004 2003 2002 Other

All Journal Article (41 results) Book (4 results) Publications (17 results)

  • [Journal Article] 新薬展望2005 子宮悪性腫瘍治療薬.2005

    • Author(s)
      杉山徹 他
    • Journal Title

      医薬ジャーナル 41・S-1

      Pages: 181-188

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] 子宮頚癌・体癌における腫瘍マーカーとその利用の仕方.2005

    • Author(s)
      杉山徹 他
    • Journal Title

      成人病と生活習慣病 35・6

      Pages: 663-667

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Clinical characteristics of mucinous adenocarcinoma of the ovary2005

    • Author(s)
      Sugiyama T, et al.
    • Journal Title

      J Clin Oncol 23・16s

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Annual Research Report 2005 Final Research Report Summary
  • [Journal Article] Phase I study of paclitaxel (TXL), doxorubicin (ADM) and carboplatin (CBDCA) combination therapy (TAC) in patients with high-risk and recurrent endometrial cancer.2005

    • Author(s)
      Sugiyama T, et al.
    • Journal Title

      J Clin Oncol 23・16s

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] A Phase I/II study of weekly intraperitoneal (IP) paclitaxel (PAC) with monthly intravenous (IV) carboplatin (CBDCA) for optimal debulked epithelial ovarian cancer (EOC) with peritoneal desease (PED)2005

    • Author(s)
      Sugiyama T, et al.
    • Journal Title

      J Clin Oncol 23・16s

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Clinical characteristics of clear cell adenocarcinoma of the ovary-Japan Clear Cell Carcinoma Study Group-.2005

    • Author(s)
      Sugiyama T, et al.
    • Journal Title

      J Clin Oncol 23・16s

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Annual Research Report 2005 Final Research Report Summary
  • [Journal Article] 「研究成果報告書概要(和文)」より2005

    • Author(s)
      Sugiyama T, et al.
    • Journal Title

      J Clin Oncol 23・16s

    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Clinical characteristics of mucinous adenocarcinoma of the ovary.2005

    • Author(s)
      Shimada M, Kigawa J, Nishimura R, Suzuki M, Kita T, Sugiyama T, Hiura M, Kaku T, Tsuda H, Terakawa M.
    • Journal Title

      J Chin Oncol 23

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Phase I study of paclitaxel (TXL), doxorubicin (ADM) and carboplatin (CBDCA) combination therapy (TAC) in patients with high-risk and recurrent endometrial cancer.2005

    • Author(s)
      Sugiyama T, Omi H, Kigawa J, Hatae M, Suzuki M, Tsuda H.
    • Journal Title

      J Chin Oncol 23

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] A phase I/II study of weekly intraperitoneal (IP) paclitaxel (PAC) with monthly intravenous (IV) carboplatin (CBDCA) for optimal debulked epithelial ovarian cancer (EOC) with peritoneal desease (PED).2005

    • Author(s)
      Takeuchi S, Terai Y, Yamaguchi H, Yamabe S, Ueda M, Ueki M, Maruo T, Sugiyama T
    • Journal Title

      J Clin Oncol 23

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Clinical characteristics of clear cell adenocarcinoma of the ovary-Japan Clear Cell Carcinoma Study Group-.2005

    • Author(s)
      Takano M, Kita T, Kikuchi Y, Yaegashi N, Kuzuya K, Tsuda H, Suzuki M, Kigawa J, Takeuchi S, Sugiyama T.
    • Journal Title

      J Chin Oncol 23

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Phase II study of ironotecan plus oral etoposide in patients with platinum and taxane-resistant ovarian cancer.2005

    • Author(s)
      Nishio S, Sugiyama T, Shoji T, Kitagawa R, Ushijima K, Kamura T.
    • Journal Title

      J Chin Oncol 23

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] 新薬展望2005子宮悪性腫瘍治療薬.2005

    • Author(s)
      杉山 徹 他
    • Journal Title

      医薬ジャーナル 41・S-1

      Pages: 181-188

    • Related Report
      2005 Annual Research Report
  • [Journal Article] 子宮頚癌・体癌における腫瘍マーカーとその利用の仕方.2005

    • Author(s)
      杉山 徹 他
    • Journal Title

      成人病と生活習慣病 35・6

      Pages: 663-667

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Phase I study of paclitaxel (TXL),doxorubicin (ADM) and carboplatin (CBDCA) combination therapy (TAC) in patients with high-risk and recurrent endometrial cancer.2005

    • Author(s)
      Sugiyama T, et al.
    • Journal Title

      J Clin Oncol 23・16s

    • Related Report
      2005 Annual Research Report
  • [Journal Article] A phase I/II study of weekly intraperitoneal (IP) paclitaxel (PAC) with monthly intravenous (IV) carboplatin (CBDCA) for optimal debulked epithelial ovarian cancer (EOC) with peritoneal desease (PED)2005

    • Author(s)
      Sugiyama T, et al.
    • Journal Title

      J Clen Oncol 23・16s

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Phase II study of ironotecan plus oral etoposide in patients with platinum and taxane-resistant ovarian cancer.2005

    • Author(s)
      Sugiyama T, et al.
    • Journal Title

      J Clin Oncol 23・16s

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Vaccination with pre-designated or evidence-based peptides for patients with recurrent gynecologic cancers.2004

    • Author(s)
      Tsuda N, Mochizuki K, Harada M, Sukehiro A, Kawano Koichiro, Yaniada A, Ushijima K, Sugiyama T, Nishida T, Yamada H, Itoh K, Kamura T.
    • Journal Title

      J Immunother 27

      Pages: 60-72

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Clinicopathologic study of 56 patients with endometrial cancer during or after adjuvant tamoxifen use for their breast cancers.2004

    • Author(s)
      Hachisuga T, Saito T, Kigawa J, Ohwada M, Yamazawa K, Yasue A, Iwasaka T, Sugiyama T, Kita T, Nagai N.
    • Journal Title

      Gynecol Oncol 95

      Pages: 139-144

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Vaccination with pre-designated or evidence-based peptides for patients with recurrent gynecologic cancers.2004

    • Author(s)
      Sugiyama T, et al.
    • Journal Title

      J Immunother 27

      Pages: 60-72

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Clinicopathologic study of 56 patients with endometrial cancer during or after adjuvant tamoxifen use for their berast cancers.2004

    • Author(s)
      Sugiyama T, et al.
    • Journal Title

      Gynecol Oncol 95

      Pages: 139-144

    • Related Report
      2004 Annual Research Report
  • [Journal Article] 更年期障害にみられた難治性外陰部自発痛に対する桂枝茯苓丸の臨床効果と病態に関する東洋医学的一考察2004

    • Author(s)
      杉山徹 他
    • Journal Title

      産婦人科漢方研究のあゆみ 21

      Pages: 108-110

    • Related Report
      2004 Annual Research Report
  • [Journal Article] 卵巣癌に対するsecond-line化学療法2004

    • Author(s)
      杉山徹 他
    • Journal Title

      産婦人科の実際 53・1

      Pages: 19-29

    • Related Report
      2004 Annual Research Report
  • [Journal Article] 産婦人科手術時の合併症軽減のために 進行卵巣癌2004

    • Author(s)
      杉山徹他
    • Journal Title

      産婦人科の実際 53・3

      Pages: 391-400

    • Related Report
      2004 Annual Research Report
  • [Journal Article] 漢方 卵巣がん2004

    • Author(s)
      杉山徹
    • Journal Title

      週間朝日 4/5増刊号

      Pages: 59-59

    • Related Report
      2004 Annual Research Report
  • [Journal Article] 卵巣がん治療のCONTROVERSY (4) 初回化学療法の選択-組織型別レジメンを変えるべきか?-2004

    • Author(s)
      杉山徹
    • Journal Title

      産科と婦人科 71・9

      Pages: 1160-1164

    • Related Report
      2004 Annual Research Report
  • [Journal Article] セカンドライン化学療法の現状と問題点2004

    • Author(s)
      杉山徹
    • Journal Title

      臨床婦人科産科 58

      Pages: 1251-1255

    • Related Report
      2004 Annual Research Report
  • [Journal Article] 子宮頚癌・子宮体癌・卵巣癌の診断と治療-最新の研究動向- 卵巣癌の治療 化学療法-概論-2004

    • Author(s)
      杉山徹 他
    • Journal Title

      日本臨床 62

      Pages: 540-545

    • Related Report
      2004 Annual Research Report
  • [Journal Article] 子宮頚癌・子宮体癌・卵巣癌の診断と治療-最新の研究動向- 子宮体癌の治療 ホルモン療法-概論-2004

    • Author(s)
      杉山徹 他
    • Journal Title

      日本臨床 62

      Pages: 370-374

    • Related Report
      2004 Annual Research Report
  • [Journal Article] 性器がんと漢方2004

    • Author(s)
      杉山徹
    • Journal Title

      産婦人科治療 89

      Pages: 421-426

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Weekly 1-h paclitaxel infusion in patients with recurrent endometrial cancer : a preliminary study.2003

    • Author(s)
      Nishio S, Ota S, Sugiyama T, Matsuo G, Kawagoe H, Kumagai S, Ushijima K, Nishida T, Kamura T.
    • Journal Title

      Int J Clin Oncol 8

      Pages: 45-48

    • NAID

      50000755491

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Japanese ovarian trials : focus on irinotecan.2003

    • Author(s)
      Sugiyama T, Yakushiji M, Ochiai K, Noda K.
    • Journal Title

      ONCOLOGY 17

      Pages: 29-33

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Irinotecan (CPT-11) and cisplatin as first-line chemotherapy for advanced ovarian cancer.2002

    • Author(s)
      Sugiyama T, Yakushiji M, Kamura T, et al.
    • Journal Title

      Oncology 63(1)

      Pages: 16-22

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Polymorphisms of UDP-glucuronosyltransferase and pharmacokinetics of irinotecan.2002

    • Author(s)
      Ando Y, Ueoka H, Sugiyama T, et al.
    • Journal Title

      Ther Drug Monit 24

      Pages: 111-116

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary.2002

    • Author(s)
      Itamochi H, Junzo K, Sugiyama T, et al.
    • Journal Title

      Obstet Gynecol 100

      Pages: 281-287

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] PTEN expression is associated with prognosis for patients with advanced endometrial carcinoma undergoing postoperative chemotherapy.2002

    • Author(s)
      Kanamori Y, Kigawa J, Sugiyama T, et al.
    • Journal Title

      Int J Cancer 100

      Pages: 686-689

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Chemosensitivity of clear cell carcinoma of the ovary.2002

    • Author(s)
      Kigawa J, Itamochi H, Sugiyama T, Kikuchi Y, Suzuki M, Terakawa N.
    • Journal Title

      Recent Res Devel Cancer

      Pages: 493-506

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Advances in chemotherapy for ovarian cancer and uterine cervical cancer-Forcusing on irinotecan (CPT-11)-Res.2002

    • Author(s)
      Sugiyama T, Yakushiji M, Kamura T, et al.
    • Journal Title

      Adv.in Cancer 2

      Pages: 87-96

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Clinical Assessment of neoadjuvant chemotherapy an interval cytoreductive surgery for unressectable advanced ovarian cancer.2002

    • Author(s)
      Ushijima K, Ota S, Sugiyama T, et al.
    • Journal Title

      Int Surg 87

      Pages: 185-190

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Prognosis of patients with operable stage IB cervical cancer not undergoing class III radical hysterectomy.2002

    • Author(s)
      Ishikawa H, Fujiwara K, Mikami Y, Kohno I, Shinozuka T, Yoshida N, Nishida M, Aoki Y, Miyagi Y, Sugiyama T, Kigawa J.
    • Journal Title

      J Clin Oncol 21

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Glycogen levels in human ovarian clear cell adenocarcinoma in relation to chemosensitivity and cellular growth.2002

    • Author(s)
      Kiyozuka Y, Adachi S, Itoh K, Itani Y, Yamada T, Sugiyama T, Tsubura A.
    • Journal Title

      J Clin Oncol 21

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Book] エビデンスに基づいた癌化学療法ハンドブック2004

    • Author(s)
      杉山 徹
    • Total Pages
      2
    • Publisher
      メディカルレビュー社
    • Related Report
      2004 Annual Research Report
  • [Book] 卵巣腫瘍・卵管腫瘍2004

    • Author(s)
      杉山 徹
    • Total Pages
      9
    • Publisher
      医歯薬出版株式会社
    • Related Report
      2004 Annual Research Report
  • [Book] オンコロジストはこう治療している 婦人科がん診療と化学療法2004

    • Author(s)
      杉山 徹
    • Total Pages
      96
    • Publisher
      ヴァンメデイカル
    • Related Report
      2004 Annual Research Report
  • [Book] 14.産婦人科領域 クリニカルPETの最前線2004

    • Author(s)
      杉山 徹 他
    • Total Pages
      4
    • Publisher
      先端医療技術研究所
    • Related Report
      2004 Annual Research Report
  • [Publications] Sugiyama T, et al.: "Japanese ovarian trials : focus on irinotecan."ONCOLOGY. 17. 29-33 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Sugiyama T, et al.: "Vaccination with pre-designated or evidence-based peptides for patients with recurrent gynecologic cancers."J Immunother. (in press).

    • Related Report
      2003 Annual Research Report
  • [Publications] 杉山徹 他: "婦人科診療の再評価-その有効性と限界-癌化学療法-卵巣癌-"産婦人科の実際. 52. 289-298 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] 杉山徹 他: "局所(骨盤内)再発の取り扱い"産科と婦人科. 5. 643-650 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] 杉山徹: "卵巣腫瘍の取り扱い"日本産科婦人科学会誌. 55. 37-43 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] 杉山徹: "卵巣癌の治療 化学療法レジメンの選択-1st lineおよび2nd lineに何を選ぶか?"産婦人科の実際 臨時増刊号 ベストEBM産婦人科治療. 52. 1749-1760 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] 杉山 徹 他: "卵巣癌・絨毛癌:臨床腫瘍学"癌と化学療法社. 1245 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Sugiyama T. et al.: "Irinotecan (CPT-11) and cisplatin as first-line chemotherapy for advanced ovarian cancer"Oncology. 63(1). 16-22 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Sugiyama T. et al.: "Polymorphisms of UDP-glucuronosyltranferase and pharmacokinetics of irinotecan"Ther Drug Monit. 24. 111-116 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Sugiyama T. et al.: "PTEN expression is associated with prognosis for patients with advanced endometrial carcinoma undergoing postoperative chemotherapy"Int J Cancer. 100. 686-689 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Sugiyama T. et al.: "Weekly 1-h paclitaxel infusion in patients with recurrent endometrial cancer : a preliminary study"Int J Clin Oncol. 8. 45-48 (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] 杉山 徹 他: "卵巣外原発性腹膜癌にWeekly Paclitaxelが有効であった一例"癌と化学療法. 29. 309-312 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 杉山 徹 他: "子宮体癌FIGO IIIc期の臨床病理学的検討"日本婦人科腫瘍学会誌. 21(1). 54-59 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 杉山 徹 他: "婦人科がんにおける分子標的療法"日産婦誌. 54. 1256-1265 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 杉山 徹 他: "卵巣癌の化学療法"産婦人科の実際. 51(11). 1971-1981 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 杉山 徹 他: "進行卵巣癌再発再燃での化学療法"産婦人科の実際. 51(9). 1245-1258 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 杉山 徹 他: "卵巣明細胞腺癌の化学療法耐性機序"日本婦人科腫瘍学会. 21(1). 19-25 (2003)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2002-03-31   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi